null

Phospho-ATF2-T71 Rabbit Polyclonal Antibody (CABP0020)

SKU:
CABP0020
Product Type:
Antibody
Applications:
WB
IF
Reactivity:
Human
Mouse
Host Species:
Rabbit
Isotype:
IgG
Research Area:
Epigenetics and Nuclear Signaling
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T71 Antibody CABP0020
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T71 Antibody CABP0020
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T71 Antibody CABP0020
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T71 Antibody CABP0020
  • Epigenetics and Nuclear Signaling Antibodies 4 Anti-Phospho-ATF2-T71 Antibody CABP0020
$503
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

Phospho-ATF2-T71 Rabbit Polyclonal Antibody (CABP0020)

The Phospho-ATF2 (T71) Polyclonal Antibody (CABP0020) is a valuable tool for researchers studying the ATF2 protein and its phosphorylation at threonine 71. This antibody, generated in rabbits, is known for its high specificity and sensitivity in detecting phospho-ATF2 (T71) in human samples, making it a reliable choice for Western blot applications.ATF2 is a transcription factor that plays a crucial role in cellular responses to stress and various stimuli, including UV radiation, oxidative stress, and inflammatory signals. Phosphorylation of ATF2 at T71 is known to regulate its transcriptional activity, impacting gene expression involved in cell growth, apoptosis, and proliferation.

Understanding the phosphorylation status of ATF2 at T71 is essential for unraveling its functions in different cellular processes and pathologies.Researchers investigating signaling pathways, cancer biology, and cellular stress responses will find the Phospho-ATF2 (T71) Polyclonal Antibody (CABP0020) to be a valuable asset in their studies. Its ability to specifically detect phosphorylated ATF2 at T71 provides insights into the regulatory mechanisms governing ATF2 activity, opening new avenues for research in cancer therapeutics and targeted treatments.